title: Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
authors: Irini
authors: I
authors: Daskalaki
authors: Jaehyun
authors: J
authors: Byun
authors: M Christina
authors: MC
authors: Dogbey
authors: Cymara
authors: C
authors: Tolbert-Warren
authors: Barbara M
authors: BM
authors: Watson
mesh_terms: D000293:Adolescent; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D054796:Drug Dosage Calculations; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D055985:Latent Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000502:physiology; D010349:Patient Compliance; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin